Showing 61 - 80 results of 66,610 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 10 ((nm decrease) OR (mean decrease)) ))', query time: 0.93s Refine Results
  1. 61
  2. 62

    Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant. by Esther Magdalena Marquez-Lona (4183126)

    Published 2017
    “…<p>(A) Lysates from strains in stationary phase (A<sub>600</sub>>5.0) were subjected to native gel electrophoresis followed by an in-gel activity assay with the fluorogenic proteasome substrate Suc-LLVY-AMC. …”
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68

    Bufalin downregulates SRC–3 and decreases cell viability in TNBC cells. by Xianzhou Song (803006)

    Published 2015
    “…<p>(A) Western blot shows that bufalin (100 nM) downregulates SRC–3 protein levels in TNBC cells. …”
  9. 69
  10. 70
  11. 71
  12. 72

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”
  13. 73

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”
  14. 74
  15. 75
  16. 76

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…(F) Increasing concentrations to 50 nM still enhances clonogenic survival of HBEC 30KT, but actually seems to decrease survival in HCC 4017 after 3 Gy radiation. …”
  17. 77
  18. 78

    Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

    Published 2013
    “…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”
  19. 79
  20. 80